期刊文献+

弥漫大B细胞淋巴瘤患者尿液中挥发性标志物的筛选 被引量:1

The screening of urinary volatile markers for diffuse large B-cell lymphoma
下载PDF
导出
摘要 目的筛选弥漫大B细胞淋巴瘤(DLBCL)患者尿液中有诊断价值的挥发性标志物(VOCs)。方法收集35例DLBCL患者尿液样本(DLBCL组),30例健康者尿液样本(对照组)。利用顶空气体固相微萃取联用气相色谱-质谱检测分析两组尿液样本中的挥发性有机化合物。应用Wilcoxon非参数检验分析筛选DLBCL患者尿液中的特异性VOCs。结果筛选出正己烷、2-丁酮和4-庚酮3种特异性挥发性标志物。DLBCL组正己烷的浓度为(63.45±9.98)μg/ml,2-丁酮的浓度为(105.43±12.81)μg/ml,4-庚酮的浓度为(162.56±25.38)μg/ml。3种物质的浓度在DLBCL组和对照组之间差异有统计学意义(P<0.05)。结论 DLBCL患者尿液中挥发性化合物(正己烷、2-丁酮和4-庚酮)可能是有诊断价值的VOCs。 Objective To screen urinary volatile organic compounds( VOCs) in diffuse large B-cell lymphoma( DL-BCL) patients . Methods The urine samples were collected from 35 DLBCL patients and 30 healthy controls. VOCs were extracted with head space solid phase micro-extract ( SPME ) combined with the gas chromatography ( GC)-masss pectrometry( MS) . The non-parametric Wilcoxon test was used for discriminating the VOCs and asses-sing the statistical significance. Results Hexane, 2-butanone and 4-heptanone were found as the specific VOCs for DLBCL. The concentration range of the hexane was(63. 45 ± 9. 98) μg/ml,and the concentration range of 2-buta-none was(105. 43 ± 12. 81) μg/ml. As for the concentration range of 4-heptanone, it was (162. 56 ± 25. 38) μg/ml. The concentration of the three VOCs was significantly different between DLBCL patients and healthy controls( P〈0. 05). Conclusion Hexane, 2-butanone and 4-heptanone may be the latent volatile biomarkers for the diagno-sis of patients with DLBCL.
出处 《安徽医科大学学报》 CAS 北大核心 2015年第4期522-525,共4页 Acta Universitatis Medicinalis Anhui
关键词 弥漫大B细胞淋巴瘤 尿液 挥发性标志物 气相色谱-质谱 diffuse large B-cell lymphoma urinie volatile organic compounds gas chromatography-mass spectrometry
  • 相关文献

参考文献10

  • 1Carbone A, Gloghini A, Kwong Y L, et al. Diffuse large B cell lym- phoma:using pathologic and molecular biomarkers to define sub- groups for novel therapy[J]. Ann Hemato1,2014,93 (8) :1263 -77.
  • 2Pauling L, Robinson A B, Teranishi R, et al. Quantitative analysis of urine vapor and breath by gas-liquid partition chromatography [ J]. Proc Natl Acad Sei USA, 1971,68 (10) :2374 - 6.
  • 3Silva C L, Passos M, Catmara J S. Investigation of urinary volatile organic metabolites as potential cancer biomarkers by solid-phase microextraction in combination with gas chromatography-mass spec- trometry [ J ]. Br J Cancer,2011,105 ( 12 ) : 1894 - 904.
  • 4Guadagni R, Miraglia N, Simonelli A, et al. Solid-phase microex- traction-gas chromatography-mass spectrometry method validation for the determination of endogenous substances: urinary hexanal and heptanal as lung tumor bio-markers [ J ]. Anal Chim Acta, 2011,701 ( 1 ) :29 -36.
  • 5Birben E, Sahiner U M, Sackesen C, et al. Oxidative stress and an- tioxidant defense [ J ]. World Allergy Organ J ,2012,5 ( 1 ) : 9 - 19.
  • 6Hietanen E, Bartsch H, Bereziat J C, et al. Diet and oxidative stress in breast, colon and prostate cancer patients : a case - con- trol study[ J]. Eur J Clin Nutr, 1994,48 (8) :575 - 86.
  • 7McDonnell A M,Dang C H. Basie review of the eytochrome p450 system [ J ]. J Adv Pratt Oncol,2013,4 (4) :263 - 8.
  • 8宋耕,秦涛,刘虎,徐国兵,熊福星,孙国平,顾康生,陈振东.早期肺癌患者呼气中痕量挥发性有机化合物的定量检测[J].安徽医科大学学报,2008,43(3):323-325. 被引量:22
  • 9Cozzolino R, De Magistris L, Saggese P, et al. Use of solid-phase microextraction coupled to gas chromatography-mass spectrometry for determination of urinary volatile organic compounds in autistic children compared with healthy controls[ J]. Anal Bioanal Chem, 2014,406(19) :4649 -62.
  • 10Hakim M, Broza Y Y, Barash O, et al. Volatile organic compounds of lung cancer and possible biochemical pathways[ J]. Chem Rev, 2012,112(11) :5949 -66.

二级参考文献8

  • 1Wolfram M, Jochen K, Gabriele F E, et al. Diagnostic potential of breath analysis-focus on volatile organic compounds [ J ]. Clin Chim Acta, 2004,347( 1 ) :25 -39.
  • 2Hietanen E, Bartsch H, Bereziat J C, et al. Diet and oxidative stress in breast, colon and prostate cancer patients: a case-control study[J]. Eur J Clin Nutr, 1994,48(8) :575 -86.
  • 3Mamett L J. Oxyradicals and DNA damage [ J ]. Carcinogenesis, 2000,21(3) :361-70.
  • 4Kneepkens C M, Lepage G, Roy C C. The potential of the hydrocarbon breath test as a measure of lipid peroxidation [ J ]. Free Radic Biol Meal,1994,17(2) :127 -60.
  • 5Pauling L, Robinson A B, Teranishi R, et al. Quantitative analysisof urine vapor and breath by gas-liquid partition chromatography [J]. Proc Natl Acad Sci USA, 1971,68(10) :2374-6.
  • 6Phillips M, Cataneo R N, Cummin A R, et al. Detection of lung cancer with volatile markers in the breath [ J ]. Chest, 2003,123 (6) :2115 -23.
  • 7O'Neill H J, Gordon S M, O'Neill M H, et al. A computerized classification technique for screening for the presence of breath biomarkers in lung cancer[J]. Clin Chem, 1988,34(8) :1613 -8.
  • 8Steeghs M M, Cristescu S M, Harren F J. The suitability of Tedlar bags for breath sampling in medical diagnostic research[ J]. Physiol Meas, 2007, 28(1):73 -84.

共引文献21

同被引文献13

  • 1Peng G, Hakim M, Broza Y Y, et al. Detection of lung, breast, colo- rectal and prostate cancers from exhaled breath using a single array of nanosensors[ J]. Br J Cancer,2010,103(4) :542-51.
  • 2Schmutzhard J, Rieder J, Deibl M, et al. Piolt study : volatile organic compounds as a diagnostic marker for head and neck tumors[J]. Head Neck,2008,30(6) :743 -9.
  • 3Birben E, Sahiner U M, Sackesen C, et al. Oxidative stress and an- tioxidant defense[J]. World Allergy Organ J,2012,5( 1 ) :9 - 19.
  • 4Klaunig J E, Wang Z,Pu X,et al. Oxidative stress and oxidative damage in chemical carcinogenesis [ J ]. Toxicol Appl Pharmacol, 2011,254(2) :86-99.
  • 5Kneepkens C M, Lepage G, Roy C C. The potential of the hydrocar- bon breath test as a measure of lipid peroxidation[ J]. Free Radic Biol Med, 1994,17 (2) : 127 - 60.
  • 6Gaspar E M, Lucena A F, Duro da Costa J, et al. Organic metaho- lites in exhaled human breath-a multivariate approach for identifi- cation of biomarkers in lung disorders [ J ]. J Chromatogr A,2009, 1216(14) :2749 -56.
  • 7Amann A, Corradi M, Mazzone P, et al. Lung cancer biomarkers in exhaled breath[J]. Expert Rev Mol Diagn ,2011,11 (2) :207 - 17.
  • 8Brunner C, Szymczak W, Hollriegl V,et al. Discrimination of can- cerous and non-cancerous cell lines by headspace-analysis with PTR-MS[ J]. Anal Bioanal Chem,2010,397 (6) :2315 - 24.
  • 9Belda-Iniesta C, de Castro Carpeo J, Carrasco J A, et al. New screening method for lung cancer by detecting volatile organic com- pounds in breath[ J]. Clin Transl Oncol,2007,9(6) :364- 8.
  • 10Martinez-Outschoorn U E,Balliet R M, Lin Z, et al. Hereditary o- varian cancer and two-compartment tumor metabolism: epithelial loss of BRCA1 induces hydrogen peroxide production, driving oxi- dative stress and NFKB activation in the tumor stroma[ J]. Cell Cy- cle,2012,11 (22) :4152 - 66.

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部